Takeda investors back $59 billion Shire deal, but wary of debt load
2018-12-5 03:51 pm
Takeda Pharmaceutical shareholders approved on Wednesday its $59 billion takeover of London-listed Shire , creating a global powerhouse with a stronger drugs pipeline but one that is saddled with massive debt.
Read The Rest at
Thomas Cook shares climb 45 percent but bonds...
Thyssenkrupp's top shareholder appoints...
You May Also Like
'Lemon' or not, Trump stuck with Phase 1 China...
Qatar Petroleum signs $19 billion shipbuilding...
UPI makes a strong comeback, records 1.2...
Clint Bowyer: “I’m ready to have fans back ......
Work out your core muscles in just minutes with...
SBI tops UPI transactions with over a billion...
Berlin / Germany
Sydney / Australia
All Rights Reserved
Powered By RSS-Script Light Version